Jip T van Dinter

Princess Maxima Ctr Pediat Oncol

Claim

基本信息

Career Trajectory

Bio

No content for now

Research Interests

Papers共 24 篇Author StatisticsCo-AuthorSimilar Experts

By YearBy Citation主题筛选期刊级别筛选合作者筛选合作机构筛选

时间

引用量

主题

期刊级别

合作者

合作机构

Detection of Human Unannotated Microproteins by Mass Spectrometry-Based Proteomics: a Community Assessment

Aaron Wacholder,Eric W Deutsch,Leron W Kok,Jip T van Dinter, Jiwon Lee,James C Wright,Sebastien Leblanc, Ayodya H Jayatissa,Kevin Jiang, Ihor Arefiev, Kevin Cao, Francis Bourassa, Felix-Antoine Trifiro,Michal Bassani-Sternberg,Pavel V Baranov,Annelies Bogaert,Sonia Chothani,Ivo Fierro-Monti,Daria Fijalkowska,Kris Gevaert,Norbert Hubner,Jonathan M Mudge,Jorge Ruiz-Orera, Jana Schulz,Juan Antonio Vizcaino,John R Prensner,Marie A Brunet,Thomas F Martinez,Sarah A Slavoff,Xavier Roucou,Jyoti S Choudhary,Sebastiaan van Heesch,Robert L Moritz,Anne-Ruxandra Carvunis

bioRxiv the preprint server for biology (2025)

Cited0Views0WOSBibtex

Figure S16 from the Neo-Open Reading Frame Peptides That Comprise the Tumor Framome Are a Rich Source of Neoantigens for Cancer Immunotherapy

Michael V. Martin,Salvador Aguilar-Rosas,Katka Franke,Mark Pieterse,Jamie van Langelaar,Renée Schreurs,Maarten F. Bijlsma,Marc G. Besselink,Jan Koster,Wim Timens,Mustafa Khasraw,David M. Ashley,Stephen T. Keir,Christian H. Ottensmeier,Emma V. King,Joanne Verheij,Cynthia Waasdorp,Peter J.M. Valk,Sem A.G. Engels,Ellen Oostenbach,Jip T. van Dinter,Damon A. Hofman,Juk Yee Mok,Wim J.E. van Esch,Hanneke Wilmink,Kim Monkhorst,Henk M.W. Verheul,Dennis Poel,T. Jeroen N. Hiltermann,Léon C.L.T. van Kempen,Harry J.M. Groen,Joachim G.J.V. Aerts,Sebastiaan van Heesch,Bob Löwenberg,Ronald Plasterk,Wigard P. Kloosterman

crossref（2024）

Cited0Views0Bibtex

Figure S9 from the Neo-Open Reading Frame Peptides That Comprise the Tumor Framome Are a Rich Source of Neoantigens for Cancer Immunotherapy

crossref（2024）

Cited0Views0Bibtex

Figure S15 from the Neo-Open Reading Frame Peptides That Comprise the Tumor Framome Are a Rich Source of Neoantigens for Cancer Immunotherapy

crossref（2024）

Cited0Views0Bibtex

The Neo-Open Reading Frame Peptides That Comprise the Tumor Framome Are a Rich Source of Neoantigens for Cancer Immunotherapy

Michael V. Martin,Salvador Aguilar-Rosas,Katka Franke,Mark Pieterse,Jamie van Langelaar,Renee Schreurs,Maarten F. Bijlsma,Marc G. Besselink,Jan Koster,Wim Timens,Mustafa Khasraw,David M. Ashley,Stephen T. Keir,Christian H. Ottensmeier,Emma V. King,Joanne Verheij,Cynthia Waasdorp,Peter J. M. Valk,Sem A. G. Engels,Ellen Oostenbach,Jip T. van Dinter,Damon A. Hofman,Juk Yee Mok,Wim J. E. van Esch,Hanneke Wilmink,Kim Monkhorst,Henk M. W. Verheul,Dennis Poel,T. Jeroen N. Hiltermann,Leon C. L. T. van Kempen,Harry J. M. Groen,Joachim G. J. V. Aerts,Sebastiaan van Heesch,Bob Loewenberg,Ronald Plasterk,Wigard P. Kloosterman

CANCER IMMUNOLOGY RESEARCH（2024）

Cited1Views0WOSBibtex

Figure S13 from the Neo-Open Reading Frame Peptides That Comprise the Tumor Framome Are a Rich Source of Neoantigens for Cancer Immunotherapy

crossref（2024）

Cited0Views0Bibtex

Figure S1 from the Neo-Open Reading Frame Peptides That Comprise the Tumor Framome Are a Rich Source of Neoantigens for Cancer Immunotherapy

crossref（2024）

Cited0Views0Bibtex

Figure S2 from the Neo-Open Reading Frame Peptides That Comprise the Tumor Framome Are a Rich Source of Neoantigens for Cancer Immunotherapy

crossref（2024）

Cited0Views0Bibtex

Figure S5 from the Neo-Open Reading Frame Peptides That Comprise the Tumor Framome Are a Rich Source of Neoantigens for Cancer Immunotherapy

crossref（2024）

Cited0Views0Bibtex

Figure S3 from the Neo-Open Reading Frame Peptides That Comprise the Tumor Framome Are a Rich Source of Neoantigens for Cancer Immunotherapy

crossref（2024）

Cited0Views0Bibtex

Author Statistics

#Papers: 24

#Citation: 52

H-Index: 3

G-Index: 6

Sociability: 5

Diversity: 1

Activity: 12

Co-Author

Co-Institution

D-Core

合作者
学生
导师

No result temporarily, you can search similar Scholar with the same research interest

Data Disclaimer

The page data are from open Internet sources, cooperative publishers and automatic analysis results through AI technology. We do not make any commitments and guarantees for the validity, accuracy, correctness, reliability, completeness and timeliness of the page data. If you have any questions, please contact us by email: report@aminer.cn